Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen

Prostate cancer (PCa) is one of the cancer types that most affects males worldwide and is among the highest contributors to cancer mortality rates. Therefore, there is an urgent need to find strategies to improve the diagnosis of PCa. Microtechnologies have been gaining ground in biomedical devices,...

Full description

Bibliographic Details
Main Authors: Filipa C. Flora, Sofia B. Relvas, Francisca A. e Silva, Mara G. Freire, Virginia Chu, João Pedro Conde
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biosensors
Subjects:
Online Access:https://www.mdpi.com/2079-6374/13/3/334
_version_ 1797613192509128704
author Filipa C. Flora
Sofia B. Relvas
Francisca A. e Silva
Mara G. Freire
Virginia Chu
João Pedro Conde
author_facet Filipa C. Flora
Sofia B. Relvas
Francisca A. e Silva
Mara G. Freire
Virginia Chu
João Pedro Conde
author_sort Filipa C. Flora
collection DOAJ
description Prostate cancer (PCa) is one of the cancer types that most affects males worldwide and is among the highest contributors to cancer mortality rates. Therefore, there is an urgent need to find strategies to improve the diagnosis of PCa. Microtechnologies have been gaining ground in biomedical devices, with microfluidics and lab-on-chip systems potentially revolutionizing medical diagnostics. In this paper, it is shown that prostate-specific antigen (PSA) can be detected through an immunoassay performed in a microbead-based microfluidic device after being extracted and purified from a serum sample through an aqueous biphasic system (ABS). Given their well-established status as ABS components for successful bioseparations, ionic liquids (ILs) and polymers were used in combination with buffered salts. Using both IL-based and polymer-based ABS, it was demonstrated that it is possible to detect PSA in non-physiological environments. It was concluded that the ABS that performed better in extracting the PSA from serum were those composed of tetrabutylammonium chloride ([N<sub>4444</sub>]Cl) and tetrabutylphosphonium bromide ([P<sub>4444</sub>]Br), both combined with phosphate buffer, and constituted by polyethylene glycol with a molecular weight of 1000 g/mol (PEG1000) with citrate buffer. In comparison with the assay with PSA prepared in phosphate-buffered saline (PBS) or human serum in which no ABS-mediated extraction was applied, assays attained lower limits of detection after IL-based ABS-mediated extraction. These results reinforce the potential of this method in future point-of-care (PoC) measurements.
first_indexed 2024-03-11T06:51:24Z
format Article
id doaj.art-3da2ad718cef437aad854ad3389cbaf0
institution Directory Open Access Journal
issn 2079-6374
language English
last_indexed 2024-03-11T06:51:24Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Biosensors
spelling doaj.art-3da2ad718cef437aad854ad3389cbaf02023-11-17T09:53:54ZengMDPI AGBiosensors2079-63742023-03-0113333410.3390/bios13030334Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific AntigenFilipa C. Flora0Sofia B. Relvas1Francisca A. e Silva2Mara G. Freire3Virginia Chu4João Pedro Conde5Instituto de Engenharia de Sistemas e Computadores-Microsistemas e Nanotecnologias (INESC MN), 1000-029 Lisbon, PortugalInstituto de Engenharia de Sistemas e Computadores-Microsistemas e Nanotecnologias (INESC MN), 1000-029 Lisbon, PortugalCICECO—Instituto de Materiais de Aveiro, Departamento de Química, Universidade de Aveiro, 3810-193 Aveiro, PortugalCICECO—Instituto de Materiais de Aveiro, Departamento de Química, Universidade de Aveiro, 3810-193 Aveiro, PortugalInstituto de Engenharia de Sistemas e Computadores-Microsistemas e Nanotecnologias (INESC MN), 1000-029 Lisbon, PortugalInstituto de Engenharia de Sistemas e Computadores-Microsistemas e Nanotecnologias (INESC MN), 1000-029 Lisbon, PortugalProstate cancer (PCa) is one of the cancer types that most affects males worldwide and is among the highest contributors to cancer mortality rates. Therefore, there is an urgent need to find strategies to improve the diagnosis of PCa. Microtechnologies have been gaining ground in biomedical devices, with microfluidics and lab-on-chip systems potentially revolutionizing medical diagnostics. In this paper, it is shown that prostate-specific antigen (PSA) can be detected through an immunoassay performed in a microbead-based microfluidic device after being extracted and purified from a serum sample through an aqueous biphasic system (ABS). Given their well-established status as ABS components for successful bioseparations, ionic liquids (ILs) and polymers were used in combination with buffered salts. Using both IL-based and polymer-based ABS, it was demonstrated that it is possible to detect PSA in non-physiological environments. It was concluded that the ABS that performed better in extracting the PSA from serum were those composed of tetrabutylammonium chloride ([N<sub>4444</sub>]Cl) and tetrabutylphosphonium bromide ([P<sub>4444</sub>]Br), both combined with phosphate buffer, and constituted by polyethylene glycol with a molecular weight of 1000 g/mol (PEG1000) with citrate buffer. In comparison with the assay with PSA prepared in phosphate-buffered saline (PBS) or human serum in which no ABS-mediated extraction was applied, assays attained lower limits of detection after IL-based ABS-mediated extraction. These results reinforce the potential of this method in future point-of-care (PoC) measurements.https://www.mdpi.com/2079-6374/13/3/334microfluidicsprostate-specific antigenhuman serumaqueous biphasic systemsionic liquidsextraction
spellingShingle Filipa C. Flora
Sofia B. Relvas
Francisca A. e Silva
Mara G. Freire
Virginia Chu
João Pedro Conde
Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
Biosensors
microfluidics
prostate-specific antigen
human serum
aqueous biphasic systems
ionic liquids
extraction
title Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
title_full Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
title_fullStr Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
title_full_unstemmed Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
title_short Combined Use of Ionic Liquid-Based Aqueous Biphasic Systems and Microfluidic Devices for the Detection of Prostate-Specific Antigen
title_sort combined use of ionic liquid based aqueous biphasic systems and microfluidic devices for the detection of prostate specific antigen
topic microfluidics
prostate-specific antigen
human serum
aqueous biphasic systems
ionic liquids
extraction
url https://www.mdpi.com/2079-6374/13/3/334
work_keys_str_mv AT filipacflora combineduseofionicliquidbasedaqueousbiphasicsystemsandmicrofluidicdevicesforthedetectionofprostatespecificantigen
AT sofiabrelvas combineduseofionicliquidbasedaqueousbiphasicsystemsandmicrofluidicdevicesforthedetectionofprostatespecificantigen
AT franciscaaesilva combineduseofionicliquidbasedaqueousbiphasicsystemsandmicrofluidicdevicesforthedetectionofprostatespecificantigen
AT maragfreire combineduseofionicliquidbasedaqueousbiphasicsystemsandmicrofluidicdevicesforthedetectionofprostatespecificantigen
AT virginiachu combineduseofionicliquidbasedaqueousbiphasicsystemsandmicrofluidicdevicesforthedetectionofprostatespecificantigen
AT joaopedroconde combineduseofionicliquidbasedaqueousbiphasicsystemsandmicrofluidicdevicesforthedetectionofprostatespecificantigen